We reported that patients with unmutated IGHV4-34+ HCL, indistinguishable from classic HCL immunophenotypically, have clinical features more like HCLv than HCL, including poor response to single-agent purine analog [13]. Here, IGHV4-34 is linked to hairy cell leukemia.